Alnylam Pharmaceuticals Inc (NAS:ALNY)
$ 147.76 -1.59 (-1.06%) Market Cap: 18.69 Bil Enterprise Value: 17.83 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 68/100

Alnylam Pharmaceuticals Inc at Needham Healthcare Conference Transcript

Apr 14, 2020 / 12:40PM GMT
Release Date Price: $120.72 (+1.44%)
Alan Carr
Needham & Company, LLC, Research Division - Senior Analyst

All right. Good morning, everyone. This is Alan Carr. I am a biotech research analyst here at Needham. Welcome to the 19th Annual Needham Healthcare Conference. This is our first virtual health care conference. Sorry for the slight technical delay, but we're off and running now. So with me, I have Barry Greene, President of Alnylam. Good morning, Barry. How are you?

Barry E. Greene
Alnylam Pharmaceuticals, Inc. - President

Good morning, Alan. I appreciate you and Needham having us here today.

Questions & Answers

Alan Carr
Needham & Company, LLC, Research Division - Senior Analyst

I am Glad you could join us. So we've got a few topics that we want to run through until 9:15 this morning. Let's start off with yesterday's news. I guess if you -- you did spend a call on it yesterday. So -- but I do want to give you just a minute or so to give us an update on the Blackstone financing and then maybe we can run through some of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot